Scoopfeeds — Intelligent news, curated.
Stifel raises MBX Biosciences stock price target to $56 on obesity data
business

Stifel raises MBX Biosciences stock price target to $56 on obesity data

Investing.com · May 11, 2026, 9:12 PM · Also reported by 2 other sources

Stifel raises MBX Biosciences stock price target to $56 on obesity data

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop